Because of difficulty in measuring each antioxidant component separately and interactions among antioxidants, methods have been developed to assess the total antioxidant capacity of serum or plasma. The 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)-equivalent antioxidant capacity (TEAC) assay (1 ), the oxygen radical absorbance capacity (ORAC) assay (2 ), and the ferric reducing ability of plasma (FRAP) assay (3 ) are commonly used and have been extensively evaluated. Although comparable mean results have been obtained with the TEAC and ORAC assays (4, 5 ) , no correlation has been found between ORAC and TEAC values or between FRAP and TEAC values (6 ). This lack of correlation between TEAC and other assays is likely attributable to underestimation of overall antioxidant capacity. Underestimation may be related to the effects of dilution (7 ) and to premature measurement of inhibition percentage at a fixed time of 3 min (6 ). In fact, both the ORAC and TEAC assays are inhibition methods: a sample is added to a freeradical-generating system, and the inhibition of the free radical action is measured. This inhibition is related to the antioxidant capacity of the sample. In addition, both assay methods measure antioxidants in serum or plasma proteins, including albumin (6 ). In this study we investigated the performance of the TEAC assay, modified the procedure, and then reevaluated the TEAC for comparison with the ORAC assay.
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The TEAC assay, commercialized by Randox Laboratories Ltd., is based on the suppression of the absorbance of radical cations of 2,2Ј-azinobis(3-ethylbenzothiazoline 6-sulfonate) (ABTS) by antioxidants in the test sample when ABTS incubates with a peroxidase (metmyoglobin) and H 2 O 2 (1 ) . If the inhibition time is fixed at 3 min, as stated in the manufacturer's instructions, the added antioxidants quench ABTS radicals in a nonlinear doseresponse fashion (6 ) . To optimize the incubation period for the complete inhibition of ABTS radical formation in the system, we extended the reaction up to 40 min and monitored the absorbance changes at 3-min intervals at 600 nm (Fig. 1A) . A reaction mixture containing 20 L of
, and 4 L of Trolox (concentration range, 0 -1.65 mol/L) was incubated and subjected to spectrophotometry (Quant; Bio-Tek Instruments) at 37°C. We found that the formation of ABTS radicals increased in proportion to the incubation period until a plateau was achieved after 30 min. The higher the concentration of Trolox used in the reaction mixture, the more the absorbance of ABTS radicals was suppressed. There was a lag time, reported as the time needed for the rate of production of chromogen ABTS radicals to stabilize (8 ) . If 1.65 mol/L Trolox was incubated in the mixture, no ABTS radicals were detectable until after 15 min. The detection limit was 0.825 mol/L at 9 min, 0.413 mol/L at 6 min, and 0.206 mol/L at 3 min. The dose-response curve of standard Trolox confirmed that the reaction is nonlinear if the incubation time is fixed at 3 min. The nonlinear dose-response relationship persisted even if the incubation period was extended to 21 min; the relationship became linear only when incubation was extended beyond 24 min (R 2 Ͼ99.5%). To test the accuracy of the TEAC assay, we repeatedly measured the TEAC value of control serum from Randox (1.36 mmol/L; lot no. 144NX) without dilution for different incubation periods. When the end-point measurement was fixed at 3 min, the variation in TEAC values was Ͼ0.004 mmol/L (SD, 0.063 mmol/L; CV ϭ 3.7%) for five repeated within-batch assays. The lowest variance (Ͻ0.001 mmol/L) and CV (Ͻ1.5%) were observed when the reaction mixture was incubated Ͼ24 min. The best performance was established when 30 min was used as the end-point of the TEAC assay: the assay was linear (R 2 ϭ 0.9952; y ϭ Ϫ0.2788x ϩ 0.1469 mmol/L; variance Ͻ0.0001 mmol/L; SD, 0.015 mmol/L; CV ϭ 1.1%). This performance was maintained even when the control serum was diluted up to fourfold (from 1.36 to 0.17 mmol/ L).
The ORAC assay is based largely on the work reported by Glazer (9 ) and modified by Cao and Prior (10 ) , in which the decrease in fluorescence of B-or R-phycoerythrin (PE) is measured in the presence of 2,2Ј-azobis(2-amidinopropane) dihydrochloride, and the lag phase or rate constant for PE fluorescence decay is used to determine the antioxidant capacity of the added sample. The ORAC method is the only method that takes free radical action to completion and uses the area under the curve for quantification; it thus combines both the percentage of inhibition and the length of inhibition of free radical formation by antioxidants into a single quantity (11 ) . We considered 30 min of inhibition as an equivalent endpoint equilibrium in our modified TEAC protocol.
We compared plasma total antioxidant capacity as measured by the TEAC and ORACs assay in the same plasma samples from adult rats administered decaffeinated green tea extract (SUNPHENON DCF-1 ® ; Taiyo Kagaku Co. Ltd. ; Fig. 1B) . The Animal Research Ethics Committee of the University approved the experiments. A single dose of SUNPHENON (reconstituted to give a dose of 53.7 mg/kg (Ϫ)-epigallocatehin-3-gallate) was given to acclimatized and fasted adult female rats via a sterile gastric tube. Blood samples were collected at 0, 0.5, 1, 2, 3, 5, and 8 h after administration. Total plasma ORAC was measured as described previously (10 ) (4, 5 ) . Both the TEAC and ORAC assays revealed a significant 35-40% increase in total plasma antioxidant capacity (P Ͻ0.05, ANOVA) 1 h after SUNPHENON administration in rats. There was no significant difference between estimates of change in total plasma antioxidant capacity as measured by the TEAC or ORAC method.
Despite modification of the TEAC assay to improve agreement with the ORAC assay, the correlation of the two assays was not high (Fig. 1B) . The correlation was higher at higher TEAC and ORAC values (8.0 mmol Trolox-equivalents/L for both). A poor correlation may be expected because different free radical sources are used in the two methods. The TEAC assay uses exogenous ABTS radicals, whereas the ORAC assay uses peroxyl radicals. Because peroxyl radicals are the most common radicals found in the human body, ORAC measurements should be more biologically relevant. On the other hand, different antioxidants respond differently in different measurement methods. For example, uric acid in serum contributes 19% in TEAC but only 7% in ORAC assays, whereas ␣-tocopherol, ascorbic acid, and bilirubin contribute more in the TEAC assay than in the ORAC assay (6 ) . Meanwhile, it is still possible that further optimization could improve the analytical performance of both methods.
In summary, this report demonstrates that the length of the inhibition time for the TEAC assay must be taken into account when determining the total antioxidant capacity of plasma. Under our conditions, we found that 30 min of inhibition was required for complete suppression of ABTS radical formation in the TEAC assay. We validated the results from the TEAC assay at 30 min and confirmed that values were similar and correlated with the results obtained by the ORAC assay over 70 min.
This study was partially supported by the Research Grants Council of the Hong Kong Special Administrative Region (Grants CUHK4077/01M, CUHK4081/01M, and CUHK4060/02M). We thank Taiyo Kagaku Co. Ltd. (Tokyo, Japan) for the generous gift of SUNPHENON DCF-1 green tea extract tablets. Congenital disorders of glycosylation (CDG), formerly named carbohydrate-deficient glycoprotein syndrome, are rare hereditary disorders caused by mutations in the genes coding for enzymes involved in the biosynthesis of glycoproteins and other glycoconjugates (1 ). The clinical characteristics are variable, but often include psychomotor, growth, and mental retardation from early childhood. CDG are the result of defects in the assembly and transfer (type I) or processing (type II) of the glycan moieties, and as a result, the carbohydrate chains are either completely missing (type I) or structurally abnormal (type II). CDG-Ia is the most frequent subtype, with ϳ500 patients reported, whereas Ͻ100 patients have been diagnosed with types Ib-Ik and only ϳ10 with type II (IIa-IId) (1) (2) (3) (4) (5) . However, it is assumed that the limited awareness of CDG, together with their variable and unspecific clinical symptoms, contribute to underdiagnosis of these disorders (6 -8 ) .
Another reason for underdiagnosis could be that methods for CDG testing are not generally available in clinical laboratories. Testing for CDG focuses mainly on the abnormal pattern of N-linked glycans of serum transferrin. The type I pattern is characterized by an increase of transferrin glycoforms missing one or both of the entire biantennary N-glycans (9, 10 ) (traditionally named disialo-and asialotransferrin, respectively, based on the number of terminal sialic acid residues), whereas type II is characterized by increased trisialo-and monosialotransferrin, indicating the presence of truncated glycans (11) (12) (13) . A variety of laboratory techniques have been evaluated for this purpose, with isoelectric focusing being the most common and serving as the reference procedure to date. A sensitive HPLC method is widely used for detection of alcohol-induced changes in serum transferrin glycoforms [i.e., carbohydrate-deficient transferrin (CDT)] (14 ). This study examined the usefulness of this HPLC method for the detection and preliminary diagnosis of CDG.
Serum samples were obtained from nine patients with biochemically and/or genetically confirmed CDG type I (a, b, and g subtypes) and four with undefined CDG type IIx defects (The Burnham Institute). Serum samples used for comparison were obtained at the Karolinska University Hospital from 42 children and adolescents (random routine samples), 132 adults (60 female and 72 male social drinkers) (14 ), and 74 chronic alcohol misusers (17 females and 57 males) (14 ). The sera were stored at 4°C when analyzed within 2 days or stored at Ϫ70°C for longer times before analysis, conditions under which transferrin is stable (14 ). The procedures followed were approved by the ethics committee at the Karolinska University Hospital.
The HPLC system provides reproducible separation and relative quantification (limit of detection, ϳ0.05%) of the iron-saturated transferrin glycoforms with only small volumes of serum or plasma (14 ). Transferrin was ironsaturated by mixing 10 -50 L of serum (depending on the volume available) at a volume ratio of 5:1 with FeNTA (final concentration, 1.7 mmol/L). Lipoproteins were precipitated by mixing the iron-saturated sample 6:1 (by volume) with dextran sulfate and CaCl 2 (1.4 mg/L and 70 mmol/L, respectively). The samples were left at 5°C for 30 -60 min and then centrifuged at 3500g for 5 min. The clear supernatant was diluted fivefold with water and transferred to glass HPLC vials. Transferrin glycoforms were separated by use of a SOURCE ® 15Q 4.6/100 PE anion-exchange column (Amersham Biosciences) with a linear salt gradient elution on an Agilent 1100 HPLC equipped with a quaternary pump. Quantification relied on the selective absorbance of the iron-transferrin complex at 470 nm.
The distribution of serum transferrin glycoforms in controls and alcohol-misusing patients is shown in Table  1 . In children up to 3 weeks of age, 6 of 13 (46%) showed a disialotransferrin concentration below the range in older children, adolescents, and adults. Trisialotransferrin concentrations were below the adult range in 9 of 11 (82%) children 1-9 months of age and 7 of 18 (39%) of those 1-18 years of age, and penta-ϩ hexasialotransferrin concentrations were above the adult range in ϳ50% of the children
